News

What Investors Can Anticipate from Zurn Elkay Water's Earnings

What Investors Can Anticipate from Zurn Elkay Water's Earnings

What Investors Can Anticipate from Zurn Elkay Water's Earnings

Zurn Elkay Water (NYSE: ZWS) is set to reveal its quarterly earnings soon, and investors are keenly awaiting this important announcement. With analysts predicting an earnings per share (EPS) of $0.40, expectations are running high.

Current Market Sentiment Towards Zurn Elkay Water

The overall market is gearing up for Zurn Elkay Water's earnings release, as favorable guidance could influence stock performance substantially. Investors should note that positive predictions can be major catalysts for stock price reactions.

Earnings History Snapshot

In the previous quarter, Zurn Elkay Water transitioned itself with an impressive EPS that exceeded expectations by $0.06. Notably, this upbeat news resulted in a significant 12.2% increase in the share price immediately following the disclosure.

Analyzing Stock Market Performance

As of the latest trading day, Zurn Elkay Water's stocks have been priced at $46.36. In the past year, the company experienced a robust 30.04% increase in share value. Given this positive trajectory, current investors are likely feeling optimistic as they approach the company's next earnings announcement.

Evaluating Analyst Perspectives on Zurn Elkay Water

Understanding the market dynamics and sentiments surrounding Zurn Elkay Water is vital for investors. As it stands, the company enjoys a consensus rating of 'Buy' among three analysts, with an average price target of $51.67, signaling potential growth of 11.45% over the next year.

Peer Comparison in Analyst Ratings

This section offers valuable insights by comparing Zurn Elkay Water's analyst ratings with its peers, including Simpson Manufacturing Co, AAON, and Armstrong World Industries. Current trends indicate various trajectories for each company, shaping their respective market positions.

  • For Simpson Manufacturing Co, analysts currently recommend a Neutral outlook, with an anticipated price target of $187.50, suggesting a considerable potential upside of 304.44%.
  • AAON stands out with a Buy recommendation, estimating a target price of $105.00, projecting a remarkable upside of 126.49%.
  • Armstrong World Industries also holds a Buy trajectory with an average target price of $199.17, indicating a possible upside of 329.62%.

Comprehensive Peer Analysis Summary

Analyzing the broader market picture involves understanding key metrics of Zurn Elkay Water and its competitors. This peer analysis showcases where Zurn Elkay stands in comparison to others.

CompanyConsensusRevenue GrowthGross ProfitReturn on Equity
Zurn Elkay WaterBuy7.89%$202.30M3.25%
Simpson Manufacturing CoNeutral5.71%$294.45M5.43%
AAONBuy-0.64%$82.73M1.88%
Armstrong World IndustriesBuy16.30%$175.80M10.77%

Key Takeaway: Zurn Elkay Water leads its peers in terms of revenue growth, although it exhibits average figures in terms of gross profit. However, it ranks lower in return on equity among its competitors.

Discovering Zurn Elkay Water: A Closer Look

Zurn Elkay Water Solutions Corp is engaged in the design, procurement, manufacturing, and marketing of a diverse range of clean water solutions aimed at enhancing drinking water accessibility, hygiene, and sustainable water management practices. Their comprehensive product lineup serves both public and private sectors.

Diving into Zurn Elkay Water's Financials

Market Capitalization Outlook: Zurn Elkay's market capitalization positions it below industry averages, indicating its relatively smaller stature among competitors, which may reflect on perceived growth potential and the scale of operations.

Revenue Growth Insights: In the recent quarter, Zurn Elkay Water achieved a notable revenue growth figure of 7.89%, demonstrating the company's ability to increase top-line earnings relative to its market peers.

Net Margin Strength: Furthermore, Zurn Elkay Water boasts an admirable net margin of 11.36%, which showcases its effective cost management and profitability in operations.

Stellar Return on Equity: The company records a strong return on equity (ROE) of 3.25%, affirming its proficient utilization of equity to produce earnings.

Asset Utilization Challenges: However, Zurn Elkay Water's return on assets (ROA) at 1.92% suggests it might encounter challenges in optimizing returns from its asset base.

Effective Debt Management: It's also worth noting that the company maintains a solid debt-to-equity ratio of 0.36, reflecting a careful approach to debt financing and a favorable balance between debt and equity, which can be enticing for potential investors.

Frequently Asked Questions

1. When is Zurn Elkay Water’s earnings release?

Zurn Elkay Water's earnings announcement is anticipated soon, with high investor interest in the results.

2. What does the current analyst consensus predict for Zurn Elkay Water?

The consensus rating for Zurn Elkay Water is 'Buy', with a target price indicating the potential for future growth.

3. How has Zurn Elkay Water performed over the past year?

Zurn Elkay Water's stock has appreciated by over 30% in the last 52 weeks, reflecting strong market confidence.

4. What are the debt management metrics for Zurn Elkay Water?

Zurn Elkay Water employs a prudent financial strategy with a debt-to-equity ratio of 0.36, demonstrating effective management of financial obligations.

5. What is the revenue growth rate for Zurn Elkay Water?

The company's recent revenue growth rate stands at 7.89%, showcasing its improving financial health and capacity for expansion.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 16

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 25

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 24

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 22

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 14

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 19

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 20

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading

Top 5 Most Recently Viewed Articles

Upcoming Financial Results Announcement by Adaptive Biotechnologies

Updated Category News Views 148

Adaptive Biotechnologies Set to Release Q3 2025 Financials Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a pioneering biotechnology firm based in Seattle, has exciting news for its investors and stakeholders. On a scheduled date, the company plans to announce its financial results for the third quarter of 2025 following the market's closing bell. The announcement...

Continue Reading
Solordi Launches First Unreal Engine 5 Game on Solana

Updated Category News Views 101

Solordi Launches Groundbreaking Unreal Engine 5 Game Solordi is excited to announce the release of the first-ever game built on Unreal Engine 5 for the Solana blockchain. This marks a significant achievement in both the gaming and cryptocurrency sectors. This groundbreaking development showcases the creativity and expertise of Solordi's development team, which has also...

Continue Reading
CSL Seqirus Shares Important Insights on Flu Vaccine Efficacy

Updated Category News Views 60

CSL Seqirus Shares Findings at OPTIONS XII Conference CSL Seqirus recently made a substantial impact at the OPTIONS XII Conference, showcasing real-world evidence (RWE) studies that highlight the effectiveness of both cell-based and adjuvanted influenza vaccines. These studies aim to reinforce the importance of influenza vaccinations, particularly as the flu season...

Continue Reading
Solo Brands, Inc. Faces Challenges Yet Sees Growth in Q2 Results

Updated Category News Views 125

Solo Brands, Inc. Faces Challenges Yet Sees Growth in Q2 Results Solo Brands, Inc. (NYSE: SBDS), known for its innovative lifestyle brands such as Solo Stove, Chubbies, Isle, and Oru, has recently revealed its financial outcomes for the second quarter of 2025. The company, which specializes in redefining the outdoor and apparel industries, is navigating through...

Continue Reading
Scatec ASA Insider Transaction Notification

Updated Category News Views 120

Update on Insider Transactions at Scatec ASA Recently, Pål Kildemo, a key member of the board at Scatec ASA, made headlines by purchasing shares of the company. On a specific date, Kildemo acquired a total of 5,000 shares, each priced at an average of NOK 78.65. This purchase reflects his strong confidence in the company's direction and overall performance. Details of...

Continue Reading